PL2019864T3 - Wytwarzanie i zastosowania sekwencji genowych kodujących chimerowe glikozylotransferazy o optymalizowanej aktywności glikozylacji - Google Patents
Wytwarzanie i zastosowania sekwencji genowych kodujących chimerowe glikozylotransferazy o optymalizowanej aktywności glikozylacjiInfo
- Publication number
- PL2019864T3 PL2019864T3 PL07729499T PL07729499T PL2019864T3 PL 2019864 T3 PL2019864 T3 PL 2019864T3 PL 07729499 T PL07729499 T PL 07729499T PL 07729499 T PL07729499 T PL 07729499T PL 2019864 T3 PL2019864 T3 PL 2019864T3
- Authority
- PL
- Poland
- Prior art keywords
- gene sequences
- glycosyltransferase
- glycosyltransferases
- sequences encoding
- preparation
- Prior art date
Links
- 108700023372 Glycosyltransferases Proteins 0.000 title abstract 5
- 230000000694 effects Effects 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 230000013595 glycosylation Effects 0.000 title abstract 2
- 238000006206 glycosylation reaction Methods 0.000 title abstract 2
- 102000045442 glycosyltransferase activity proteins Human genes 0.000 title abstract 2
- 108700014210 glycosyltransferase activity proteins Proteins 0.000 title abstract 2
- 102000051366 Glycosyltransferases Human genes 0.000 abstract 3
- 210000005220 cytoplasmic tail Anatomy 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 239000012634 fragment Substances 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 238000011144 upstream manufacturing Methods 0.000 abstract 2
- 210000004899 c-terminal region Anatomy 0.000 abstract 1
- 230000003197 catalytic effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000004927 fusion Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 210000004897 n-terminal region Anatomy 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01087—N-Acetyllactosaminide 3-alpha-galactosyltransferase (2.4.1.87), i.e. alpha-1,3-galactosyltransferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01133—Xylosylprotein 4-beta-galactosyltransferase (2.4.1.133)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/99—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
- C12Y204/99001—Beta-galactoside alpha-2,6-sialyltransferase (2.4.99.1)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/05—Fusion polypeptide containing a localisation/targetting motif containing a GOLGI retention signal
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06290843 | 2006-05-24 | ||
| EP07729499A EP2019864B1 (en) | 2006-05-24 | 2007-05-24 | Preparation and uses of gene sequences encoding chimerical glycosyltransferases with optimized glycosylation activity |
| PCT/EP2007/055070 WO2007135194A2 (en) | 2006-05-24 | 2007-05-24 | Preparation and uses of gene sequences encoding chimerical glycosyltransferases with optimized glycosylation activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2019864T3 true PL2019864T3 (pl) | 2012-02-29 |
Family
ID=36659871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07729499T PL2019864T3 (pl) | 2006-05-24 | 2007-05-24 | Wytwarzanie i zastosowania sekwencji genowych kodujących chimerowe glikozylotransferazy o optymalizowanej aktywności glikozylacji |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8993297B2 (pl) |
| EP (1) | EP2019864B1 (pl) |
| JP (1) | JP2009537165A (pl) |
| AT (1) | ATE516346T1 (pl) |
| CA (1) | CA2653104C (pl) |
| DK (1) | DK2019864T3 (pl) |
| ES (1) | ES2368267T3 (pl) |
| PL (1) | PL2019864T3 (pl) |
| PT (1) | PT2019864E (pl) |
| WO (1) | WO2007135194A2 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6594860B2 (ja) * | 2013-05-29 | 2019-10-23 | エフ．ホフマン−ラ ロシュ アーゲー | シアル酸付加の定量的調節 |
| EP3017057B1 (en) | 2013-07-05 | 2019-10-02 | F.Hoffmann-La Roche Ag | Process for the mono- and bi-sialylation of glycoproteins employing n-terminally truncated beta-galactoside alpha-2,6-sialyltransferase mutants |
| EP2821482A1 (en) * | 2013-07-05 | 2015-01-07 | Roche Diagniostics GmbH | N-terminally truncated glycosyltransferases |
| EP2824176A1 (en) | 2013-07-11 | 2015-01-14 | Siamed'xpress | Methods for producing sialylated therapeutic proteins |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| CN107429237B (zh) * | 2014-12-22 | 2021-09-28 | 豪夫迈·罗氏有限公司 | Cmp依赖性的唾液酸酶活性 |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| PL240405B1 (pl) * | 2017-07-24 | 2022-03-28 | Zakl Farmaceutyczne Polpharma Spolka Akcyjna | Przeciwciało monoklonalne oraz sposób jego otrzymywania |
| WO2021141902A1 (en) * | 2020-01-06 | 2021-07-15 | Igm Biosciences, Inc. | Highly sialylated multimeric binding molecules |
| WO2023141513A2 (en) * | 2022-01-19 | 2023-07-27 | The Regents Of The University Of California | Functionalized human milk oligosaccharides and methods for producing them |
| WO2025088103A1 (en) * | 2023-10-26 | 2025-05-01 | Inbiose N.V. | Production of a sialylated compound |
| WO2025088102A1 (en) * | 2023-10-26 | 2025-05-01 | Inbiose N.V. | PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE COMPRISING GAL-β1,3-[NEU5AC-A2,6]-HEXNAC-R |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11512933A (ja) | 1996-08-02 | 1999-11-09 | ザ オースティン リサーチ インスティテュート | キメラグリコシルトランスフェラーゼをコード化する改良された核酸 |
| US7244601B2 (en) * | 1997-12-15 | 2007-07-17 | National Research Council Of Canada | Fusion proteins for use in enzymatic synthesis of oligosaccharides |
| ATE440959T1 (de) | 2000-06-28 | 2009-09-15 | Glycofi Inc | Verfahren für die herstellung modifizierter glykoproteine |
| US7598055B2 (en) * | 2000-06-28 | 2009-10-06 | Glycofi, Inc. | N-acetylglucosaminyltransferase III expression in lower eukaryotes |
| AU2002352253A1 (en) * | 2001-12-18 | 2003-06-30 | Bayer Healthcare Ag | Regulation of human sialyltransferase |
| WO2003093448A2 (en) | 2002-05-03 | 2003-11-13 | Neose Technologies, Inc. | Recombinant glycosyltransferase fusion proteins |
-
2007
- 2007-05-24 PL PL07729499T patent/PL2019864T3/pl unknown
- 2007-05-24 CA CA2653104A patent/CA2653104C/en not_active Expired - Fee Related
- 2007-05-24 ES ES07729499T patent/ES2368267T3/es active Active
- 2007-05-24 DK DK07729499.9T patent/DK2019864T3/da active
- 2007-05-24 EP EP07729499A patent/EP2019864B1/en not_active Not-in-force
- 2007-05-24 AT AT07729499T patent/ATE516346T1/de active
- 2007-05-24 JP JP2009511529A patent/JP2009537165A/ja active Pending
- 2007-05-24 PT PT07729499T patent/PT2019864E/pt unknown
- 2007-05-24 US US12/301,914 patent/US8993297B2/en not_active Expired - Fee Related
- 2007-05-24 WO PCT/EP2007/055070 patent/WO2007135194A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007135194A3 (en) | 2008-03-27 |
| US20100105106A1 (en) | 2010-04-29 |
| ATE516346T1 (de) | 2011-07-15 |
| WO2007135194A9 (en) | 2008-05-02 |
| EP2019864A2 (en) | 2009-02-04 |
| PT2019864E (pt) | 2011-09-06 |
| ES2368267T3 (es) | 2011-11-15 |
| EP2019864B1 (en) | 2011-07-13 |
| DK2019864T3 (da) | 2011-09-26 |
| CA2653104C (en) | 2016-08-02 |
| JP2009537165A (ja) | 2009-10-29 |
| US8993297B2 (en) | 2015-03-31 |
| WO2007135194A2 (en) | 2007-11-29 |
| CA2653104A1 (en) | 2007-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2019864E (pt) | Preparação e utilizações de sequências génicas codificando glicosiltransferases quiméricas com actividade de glicosilação optimizada | |
| NZ595497A (en) | Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them | |
| Angata et al. | Unique disulfide bond structures found in ST8Sia IV polysialyltransferase are required for its activity | |
| BR112012006032A2 (pt) | polipetídeo isolado, composição, célula hospedeira recombinante, métodos para produzir o polipetídeo, um polipetídeo tendo atividade realçadora celulolítica, um mutante de uma célula precursora, uma proteína e um produto de fermentação, planta transgênica, parte de planta ou célula de planta, molécula de rna inibidora de filamento duplo(rsrna), e, métodos para inibir a expressão de um polipetídeo tendo atividade realçadora celulolítica em uma célula, degradar ou converter um polipetídeo isolado, composição, célula hospedeira recombinante, métodos para produzir o polipetídeo, um polipetídeo tendo atividade realçadora celulolítica, um mutante de uma célula precursora, uma proteína e um produto de fermentação, planta transgênica, parte de planta ou célula de planta, molécula de rna inibidora de filamento duplo (dsrna), e, métodos para inibir a expressão de um polipetídeo tendo atividade realçadora celulolítica em uma célula, degradar ou converter um material celulósico e fermentar um material celulósico. | |
| WO2008024372A3 (en) | Pullulanase variants with increased productivity | |
| WO2010139736A3 (de) | Rekombinante herstellung von peptiden | |
| IN2012DN03823A (pl) | ||
| ES2667718T3 (es) | Métodos y composiciones para producir hidrocarburos | |
| EA200901110A1 (ru) | Рекомбинантная клетка-хозяин для получения соединения, представляющего интерес | |
| NZ593203A (en) | Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases by inserting a polypeptide coding for a non-mammalian beta1,4-galactosyltransferase | |
| ATE492633T1 (de) | Polypeptide mit cellobiohydrolaseaktivität und dafür kodierende polynukleotide | |
| MX2011010494A (es) | Polipeptidos que tienen actividad de celulasa. | |
| WO2008057637A3 (en) | Methods of increasing secretion of polypeptides having biological activity | |
| NZ596764A (en) | N-glycan core beta-galactosyltransferase and uses thereof | |
| RU2010108308A (ru) | Способ получения гетерогенных белков | |
| WO2008087035A3 (en) | Screening method for anti-diabetic compounds | |
| WO2010051049A3 (en) | Thermophilic and thermoacidophilic glycosylation genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods | |
| JP2009537165A5 (pl) | ||
| MX365095B (es) | Métodos y composiciones para incrementar la producción de ácido siálico y tratar condiciones de enfermedades relacionadas siálicas. | |
| EP2533792A4 (en) | CHEMICAL PREPARATION OF POLYUBIQUITINE CHAINS | |
| JP2014076042A5 (pl) | ||
| NZ590011A (en) | Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof | |
| MX2012001672A (es) | Vector que comprende promotor de manosa y promotor de manosa. | |
| WO2010146043A3 (en) | System for the heterologous expression of a viral protein in a ciliate host cell | |
| MX2012002187A (es) | Expresion funcional del transportador de nitrato de levadura (ynt1) en maiz para mejorar la captacion de nitrato. |